UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000036428
Receipt No. R000041499
Scientific Title A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application.
Date of disclosure of the study information 2019/04/10
Last modified on 2019/10/08 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application.
Acronym A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application.
Scientific Title A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application.
Scientific Title:Acronym A Preliminary Study of an Anti-Wrinkle Product for a 12-Week Application.
Region
Japan

Condition
Condition N/A (healthy adults)
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aims to examine an effect of an anti-wrinkle product for a 12-week application and its safety.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes [1]Indexes for evaluating skin condition (doctor's questions and assessment of skin condition(1), photo evaluation(1), skin quality evaluation(1), wrinkle topography(2)).
(1)Screening, Week 0, Week 4, Week 8, Week 12.
(2)Week 0, Week 4, Week 8, Week 12.
Key secondary outcomes [1]Questionnaires about skin condition (Week 0, Week 4, Week 8, Week 12).
[2]Subject's diary (From the first day of ingestion of a test material to the last day of the test).

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Applying test products (applying test product A [right face] vs applying test product B [left face]).
Interventions/Control_2 Applying test products (applying test product B [right face] vs applying test product A [left face]).
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
35 years-old <=
Age-upper limit
55 years-old >=
Gender Female
Key inclusion criteria [1]Japanese female aged 35-55 years.
[2]Individuals whose wrinkle grade is 3.0 -5.0*.
[3]Individuals whose do not apply cosmetics and cuasi-drugs for anti-wrinkle.
[4]Individuals who apply 1-3 products for skin care after washing.
[5]Individuals who can stop drinking alcohol during the test period.
[6]Individuals whose written informed consent has been obtained.
*Task Force Committee for Evaluation of Anti-aging Function. Guideline for Evaluation of Anti-wrinkle Products. Journal of Japanese Cosmetic Science Society, 30(4): 316-332, 2006.
Key exclusion criteria [1]Individuals with chronic skin disease, such as atopic dermatitis.
[2]Individuals with strange skin conditions at measurement points.
[3]Individuals who had been conducted an operation on the test spot.
[4]Individuals who is a patient of hay fever and take a drug.
[5]Individuals who were took a special facial treatment in the past 1 month.
[6]Individuals who have a habit to ingest supplements claiming for brightening effect.
[7]Individuals who cannot avoid daylight exposure during the test period.
[8]Individuals who had ingested health-promoting foods, foods for specified health uses, health foods, or supplements being effective for the study.
[9]Individuals who have a history of serious heart disease, kidney damage, and endocrine disease.
[10]Individuals who conduct or have conducted hormone replacement therapy for menopausal disorder.
[11]Individuals who take tabaco or alcohol regularly or whose eating habit is irregularity.
[12]Subjects who are pregnant or breast-feeding.
[13]Individuals judged inappropriate for the trial by the principal.
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Osamu
Middle name
Last name Nemoto
Organization Medical Corporation Kojinkai
Division name Chief Director
Zip code 064-0807
Address 2-1-4 Minami Nanajo Nishi, Chuo-ku, Sapporo 0640807, JAPAN
TEL +81-11-221-8807
Email sapporo@kojinkai.org

Public contact
Name of contact person
1st name Ryoma
Middle name
Last name Shimizu
Organization TES Holdings Co., Ltd.
Division name Administrative Department of Clinical Trials
Zip code 110-0015
Address 6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN
TEL +81-3-6801-8480
Homepage URL
Email r.shimizu@tes-h.co.jp

Sponsor
Institute Derma Labo, Inc.
Institute
Department

Funding Source
Organization LG Household & Health Care Ltd
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Republic of Korea

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ueno-Asagao Clinic Ethical Review Committee
Address Kairaku Building 6F, 2-7-5, Higashiueno, Taito-ku, Tokyo, 110-0015 JAPAN
Tel +81-3-6240-1162
Email i.takahashi@tes-h.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 04 Month 10 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 20
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2019 Year 03 Month 08 Day
Date of IRB
2019 Year 03 Month 12 Day
Anticipated trial start date
2019 Year 04 Month 11 Day
Last follow-up date
2019 Year 07 Month 04 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2019 Year 04 Month 06 Day
Last modified on
2019 Year 10 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041499